CORRESP Filing
Opus Genetics, Inc.
Date: April 21, 2026 · CIK: 0001228627 · Accession: 0001140361-26-015777
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-294295
Letter
April 21, 2026
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention:
Jessica Dickerson
Re:
Opus Genetics, Inc.
Registration Statement on Form S-3
File No. 333-294295
Acceleration Request
Requested Date: April 22, 2026
Requested Time: 4:00 P.M., Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Opus Genetics, Inc. (the “Company”) hereby requests that the effective date of the above-referenced Registration Statement on Form S-3 (as amended, the “Registration Statement”), be accelerated so that the Registration Statement will become effective at 4:00 P.M., Eastern Time, on April 22, 2026, or as soon thereafter as practicable or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and Exchange Commission.
Please contact Nick DeAngelis of Sidley Austin LLP at (214) 969-3563 with any questions regarding the foregoing and to confirm the effectiveness of the Registration Statement.
Very truly yours,
/s/ Dr. George Magrath
Show Raw Text
CORRESP
1
filename1.htm
April 21, 2026
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-3720
Attention:
Jessica Dickerson
Re:
Opus Genetics, Inc.
Registration Statement on Form S-3
File No. 333-294295
Acceleration Request
Requested Date: April 22, 2026
Requested Time: 4:00 P.M., Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Opus Genetics, Inc. (the “Company”) hereby requests that the effective
date of the above-referenced Registration Statement on Form S-3 (as amended, the “Registration Statement”), be accelerated so that the Registration Statement will become effective at 4:00
P.M., Eastern Time, on April 22, 2026, or as soon thereafter as practicable or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the U.S. Securities and
Exchange Commission.
Please contact Nick DeAngelis of Sidley Austin LLP at (214) 969-3563 with any questions regarding the foregoing and to confirm the effectiveness of the Registration Statement.
Very truly yours,
/s/ Dr. George Magrath
Dr. George Magrath
Chief Executive Officer
Opus Genetics, Inc.
cc:
Robert Gagnon, Opus Genetics, Inc.
Asher Rubin, Sidley Austin LLP
Istvan A. Hajdu, Sidley Austin LLP
Nick DeAngelis, Sidley Austin LLP